Back to search
Type 1 Interferonopathies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Type 1 Interferonopathies trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Type 1 Interferonopathies trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Type I interferonopathies are rare autoinflammatory disorders caused by genetic defects and associated with significant morbidity and mortality. These diseases…
Open-Label Study (Phase Ib) of Type 1 Interferonopathy patients receiving IMSB301 monotherapy.